Thousands of proteins are required to execute the diverse cellular functions essential to maintain cell and organismal viability. Proteins are in a dynamic equilibrium defined by the balance between protein synthesis and protein degradation 1 . Cellular protein levels depend on protein synthesis, folding and degradation, and failure to accurately regulate and coordinate these processes leads to disease. During cell and organismal growth, protein synthesis exceeds degradation, whereas during unfavourable conditions, such as lack of nutrients, degradation may exceed synthesis. Under normal conditions, dietary amino acids constitute only about 20% of the amino acid supply to build the proteins that an adult human synthesizes daily to maintain an essentially constant body weight 2 . The remaining ~80% of amino acids comes from the recycling of amino acids following protein degradation.
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In cells, protein degradation is achieved by two sys tems: the ubiquitin-proteasome system (UPS) (Fig. 1 ) and the autophagy-lysosome system. Autophagy is a self-eating process by which cells degrade often large cellular components, such as organelles or protein aggregates, by engulfing them in a double-membrane compartment, the autophagosome, which fuses with lysosomes 3 . This is the major form of autophagy, also known as macroautophagy, to which we refer in this Review. Other forms of autophagy, such as microautophagy and chaperonemediated autophagy, are discussed elsewhere 4 . The cellular levels of autophagy vary considerably depending on the conditions; this was discovered in yeast and also applies in mammals, with autophagy being induced by nutrient starvation 3 . Autophagy increases in response to starvation in order to recycle intracellular components into nutrients, particularly amino acids, to sustain protein synthesis and thereby enables cells to survive this challenge 5 . When nutrients are abundant, cells can survive without autophagy, and mutations or deletions in autophagy genes, which encode components of the autophagy machinery and its regulation, do not compromise cell viability 6 . In contrast to autophagy genes, the vast majority of genes encoding proteasome subunits are essential 7 because the turnover of proteins mediated by the UPS is high even when nutrients are abundant. The UPS is thought to degrade thousands of short-lived and regulatory proteins, as well as damaged and misfolded proteins, to regulate various cellular functions, including cell cycle, cell survival, apoptosis, cellular metabolism and protein quality control [8] [9] [10] [11] . The proteasome is also essential for amino acid homeostasis 12 . In order to achieve these crucial functions, the activity of the UPS must be tightly regulated.
Two types of signal target proteins for degradation by the proteasome: ubiquitylation, usually in the form of lysine 48-linked polyubiquitin chains 7, [13] [14] [15] , and the presence of an unstructured region in proteins, which serves proteasomal degradation and autophagy and how these mechanisms are integrated with cellular physiology. We also discuss how the misregulation of proteasome assembly and activity can contribute to human disease.
Components of the 26S proteasome
The eukaryotic 26S proteasome is a 2.5 MDa proteolytic complex that consists of two different subcomplexes: the 20S core particle (CP) and the 19S regulatory particle (RP) [19] [20] [21] [22] [23] (Fig. 1) . The CP is flanked at one or both ends by the RP to form the singly (RP 1 -CP) and doubly (RP 2 -CP) capped proteasome, respectively (Fig. 1) . Currently, the functional importance of singly or doubly capped proteasomes is unknown. Additional regulatory complexes can substitute for the RP to assemble alternative forms of the proteasome. The function of these alternative RPs, including proteasome activator PA200 (also known as PSME4) in mammals (Bml10 in yeast) 19, 24, 25 and the 11S regulator complex PA28 (also known as PSME3) or REG in mammals, is less clear than the function of RP 7 . Three types of PA28 subunit have been described, the α-subunit and β-subunit, which form the PA28α-β heteroheptamer (with a stoichiometry of α 4 β 3 ), and the γ-subunits induced by interferon-γ (IFNγ), which form a homoheptamer [26] [27] [28] . Because one or two RPs can be bound to the CP, this creates a number of possible hybrid proteasome assemblies, the functions of which remain to be elucidated. We use the standardized nomenclature, and the yeast and human subunit names are listed in Supplementary table 1.
The 20S core particle. Protein degradation occurs inside the narrow proteolytic chamber of the CP, a barrel-shaped cylinder composed of α-subunits and β-subunits arranged in four stacked heteroheptameric rings with a stoichiometry of α 1-7 β 1-7 β 1-7 α 1-7 (reFs 10, [29] [30] [31] ).
The two outer α-rings function as a gate that prevents uncontrolled access to the proteolytic chamber inside the two β-rings. The gate is formed by the tightly interwoven amino (N)-terminal tails of the α-subunits, which block substrate entry 7 . Gate opening controls the access of substrates inside the catalytic chamber of the proteasome and has an important role in the regulation of proteasomal degradation 7 . Among the seven β-subunits, only β1, β2 and β5 have proteolytic activities, which are known as caspase-like activity, trypsin-like activity and chymotrypsin-like activity, respectively [32] [33] [34] . Three additional β-subunits, β1i, β2i and β5i, are induced by treatment with IFNγ in mammals and replace their constitutive counterparts to form the immunoproteasome 35, 36 (Box 1). Other tissue-specific subunits, β5t and α4s, have been reported to be part of the thymoproteasome and the testis-specific proteasome, respectively 37, 38 (Box 1).
The 19S regulatory particle. The RP has the crucial functions of controlling substrate recognition, unfolding and translocation into the narrow CP after opening the gates formed by the α-ring 7, 20, 39 . The RP consists of two subcomplexes, the base and the lid. The base is composed of six distinct but related AAA + -ATPase subunits, which are referred to as RP triple-A protein 1 (Rpt1)-Rpt6. These six AAA + -ATPase proteins form Fig. 1 | The ubiquitin-proteasome system. Ubiquitylation consists of the covalent binding of ubiquitin (Ub) to lysine residues exposed at the surface of targeted substrates. Ub is first activated by the ubiquitin-activating enzyme (E1) in the presence of ATP, before being bound to E1. The ubiquitin is then transferred from E1 to the ubiquitinconjugating enzyme (E2). A ubiquitin ligase (E3) recruits the ubiquitin-bound E2 enzyme and a substrate to transfer the ubiquitin from E2 to the substrate. The formation of lysine 48-linked polyubiquitin chains, the main signal for proteasomal degradation, is mediated by successive cycles of ubiquitin conjugation. Monoubiquitylation may be sufficient for proteasome targeting. When targeted to the proteasome, substrates are degraded into short peptides, which are further broken down into amino acids by aminopeptidases (APPs). The monoubiquitin and polyubiquitin molecules are usually removed from the substrate by the proteasome by deubiquitylating enzymes (DUBs) before substrate degradation. Released free ubiquitin molecules are recycled for another round of ubiquitylation. CP, core particle; RP, regulatory particle.
as an initiator for degra-dation 16, 17 (Fig. 1) . Ubiquitylation, which involves a complex interplay of ubiquitylating and deubiquitylating enzymes (DUBs), is an important element of control of the UPS 7, 13, 14, 18 . In addition to selectively targeting proteins to the proteasome, cells have another way of regulating proteasomal degradation, which consists of adjusting proteasome abundance. Recent findings have revealed that proteasome abundance is controlled at the level of proteasome assembly, which is a highly regulated process that is finely tuned to cellular metabolism. In this Review, we describe the different steps of proteasome assembly and their regulation, the interplay between www.nature.com/nrm a heterohexameric ring that directly contacts the surface of the outer α-ring of the CP. The base has four additional non-ATPase subunits: RP non-ATPase 1 (Rpn1), Rpn2, Rpn10 and Rpn13 (reFs 40, 41 ). The lid is composed of nine non-ATPase subunits: Rpn3, Rpn5-Rpn9, Rpn11, Rpn12 and Sem1. Rpn10 was thought to be important for base-lid association 42 . However, recent cryo-electron microscopy structures revealed that other base subunits interact with the lid, indicating that the base-lid association mostly relies on the lid subunits Rpn3, Rpn7, Rpn8 and Rpn11, which make extensive contacts with base subunits, including the Rpt3-Rpt6 pair and Rpn2 (reFs 22, [43] [44] [45] ).
Mechanisms of core particle assembly CP assembly is a complex process that can be divided into three different steps in eukaryotes: α-ring formation, β-ring formation and half-proteasome dimerization and maturation (Fig. 2 ). All these steps are assisted by five proteasome assembly chaperones named proteasome biogenesis-associated 1 (Pba1)-Pba4 in yeast (proteasome assembly chaperone 1 (PAC1)-PAC4 in human) and underpinning maturation of proteasome 1 (Ump1) (proteasome maturation protein (POMP) in human) 21, 31, 46 . α-Ring formation. Among the five proteasome assembly chaperones, four are dedicated to the assembly of the α-ring, suggesting that the arrangement of the seven different α-subunits into a heptameric ring is a crucial step in CP assembly. These four assembly chaperones form two heterodimers, Pba1-Pba2 (reF. 47 ) and Pba3-Pba4
(reFs 48, 49 ). The Pba1-Pba2 complex ensures the appropriate incorporation of the α5 and α6 subunits of the α-ring and has been shown to prevent premature binding of the RP to the α-ring 50, 51 (Fig. 2) . In humans, in addition to preventing premature association with the RP, the binding of the PAC1-PAC2 heterodimer to the α-ring intermediate also prevents aberrant dimerization of α-rings 47, [50] [51] [52] . In yeast, the Pba3-Pba4 complex interacts with the α5 subunit of the intermediate to control the correct integration Box 1 | Tissue-specific proteasomes one key role of the proteasome in the immune system is to generate antigenic peptides for presentation on major histocompatibility complex (mHC) class I molecules. This process is mainly mediated by a specialized type of proteasome known as the immunoproteasome. The proteolytic subunits of the immunoproteasome differ from those of the constitutive proteasome (see the figure, parts a and b) . β1, β2 and β5 are replaced by β1i (also known as proteasome subunit-β type-9 (PSmb9)), β2i (also known as PSmb10) and β5i (also known as PSmb8), respectively [192] [193] [194] [195] [196] [197] . These immunosubunits are constitutively expressed in different immune tissues, including the thymus and the spleen, but they are also induced in a broader range of cell types following exposition to pro-inflammatory cytokines such as interferon-γ 198, 199 . The immunoproteasome exhibits elevated chymotrypsin-like and trypsin-like activities, which produce antigenic peptides harbouring hydrophobic residues that better bind mHC class I molecules. recent studies have expanded the role of the immunoproteasome in B and T cell differentiation, in response to infection and in dendritic cell activation 199, 200 . It has also been associated with various human diseases, including cancer and immune and inflammatory disorders [198] [199] [200] . Another type of specialized proteasome identified in cortical thymic epithelial cells is the thymoproteasome (see the figure, part c) . This specialized proteasome contains the two immunosubunits, β1i and β2i, as well as a thymus-specific β-subunit referred to as β5t 201 . The expression of the subunit β5t is controlled by forkhead box protein n1 (FoXn1), a transcription factor regulating thymus development 38 . The thymoproteasome is essential for the positive selection of developing T cells, a process that involves selecting T cells capable of interacting with the MHC 38, 202, 203 . The β5t subunit has substrate preference for peptide-harbouring hydrophilic side chains generating a different pool of peptides from that of the β5 and β5i subunits of the α3 and α4 subunits. The deletion of Pba3 or Pba4 thereby causes the accumulation of proteasome intermediates and produces diverse aberrant proteasomes, including proteasomes devoid of α4 and proteasomes harbouring a second copy of α4 instead of α3 (referred to as an α4-α4 proteasome) 53 . Such aberrant α4-α4 proteasomes have also been described in mammalian cells 54 . β-Ring formation. The α-ring serves as a platform for the assembly of the β-ring, which begins with the sequential recruitment of β2, β3 and β4 subunits. Ump1 is incorporated along with the first β-subunits, while the Pba3-Pba4 complex dissociates from the α-ring upon β3 integration 55, 56 . The resulting intermediate, known as the 13S complex, then recruits β5, β6, β1 and β7 to form the 15S complex, also called the half-proteasome (Fig. 2) . Half-proteasome dimerization is directly initiated after β7 incorporation [55] [56] [57] .
Half-proteasome dimerization and maturation. Ump1 prevents inappropriate dimerization of half-proteasomes by obstructing their dimerization until all β-subunits are properly incorporated 56, 58 . After half-proteasome dimerization, the resulting nascent CP is remodelled by the removal of N-terminal propeptides from the β1, β2, β5, β6 and β7 subunits. Ump1 is then degraded by the newly formed CP, while the Pba1-Pba2 complex is recycled for a new round of CP assembly 48, 58, 59 ( Fig. 2) . In contrast to the yeast Pba1-Pba2 complex, the human PAC1-PAC2 heterodimer has been shown to be degraded upon completion of CP assembly 48 .
Mechanisms of regulatory particle assembly RP assembly is a multistep process, and the two large subcomplexes, base and lid, can assemble independently (Fig. 3) . In contrast to the lid, which either self-assembles 60 or has assembly factors that have not yet been found, the assembly of the base is known to be assisted by five RP assembly chaperones (RACs): Nas2 (p27 in human), Nas6 (p28 in human), DNA mismatch repair protein Hsm3 (S5b in human), Rpn14 (proteasomal ATPase associated factor 1 (PAAF1) in human) and ATPase dedicated chaper one of 17 kDa (Adc17; also known as TMA17)) [61] [62] [63] [64] [65] [66] . The loss of a single RAC is not lethal, but the deletion of a combination of RACs is detrimental for cell survival, particularly under stress conditions 61, 63, 66 . This suggests some degree of functional overlap between the different RACs. To date, two models of RP assembly have been proposed. In one model, RP assembly is independent of the CP 61, 62 , while in the other model, the CP is used as a platform for RP base assembly [66] [67] [68] . RP base assembly. The hexameric ATPase ring of the RP has a precisely ordered Rpt1-Rpt2-Rpt6-Rpt3-Rpt4-Rpt5 configuration and is built upon assembly of three modules composed of two AAA + -ATPase pairs α β Fig. 2 | Models of 20S core particle assembly. The assembly of the core particle (CP) is initiated by the assembly of the α-ring, which serves as a platform for the assembly of the β-ring. CP assembly is assisted by five assembly chaperones referred to as proteasome biogenesis-associated 1 (Pba1)-Pba4 and underpinning maturation of proteasome 1 (Ump1). These assembly chaperones prevent aberrant dimerization of α-rings as well as premature association with the regulatory particle (RP). They also ensure that α-subunits and β-subunits are properly incorporated. Two half-proteasomes (15S) associate to form a nascent CP, which is remodelled by the successive removal of amino-terminal propeptides from β1, β2, β5, β6 and β7 subunits. Ump1 is then degraded by the newly formed CP while the Pba1-Pba2 complex is recycled.
www.nature.com/nrm bound to selective RACs that prevent premature binding of RP intermediates to the CP 66,69,70 ( Fig. 3) . Rpn14, Nas6, Nas2 and Hsm3 bind the carboxyl (C)-terminal tails of their cognate Rpt proteins forming three modules: Rpn14-Rpt6-Rpt3-Nas6, Rpt4-Rpt5-Nas2 and Hsm3-Rpt1-Rpt2-Rpn1 (reFs 21, 41 ). The first two modules associate with each other before incorporation of the Hsm3-Rpt1-Rpt2-Rpn1 complex, along with Rpn2 and Rpn13. Rpn10 is then recruited to complete the assembly of the RP base (Fig. 3) . The incorporation of the Hsm3-Rpt1-Rpt2-Rpn1 complex triggers the release of Nas2 from the base, while Rpn14, Nas6 and Hsm3 are removed upon the association between the RP and the CP 68, [71] [72] [73] . Yeasts have an additional RAC called Adc17 (reF. 65 ). Unlike the other RACs that bind to the C-terminal tails of Rpts, Adc17 assists RP assembly by binding to the N-terminal region of Rpt6 to promote the pairing of Rpt6 with Rpt3 (Fig. 3) . The Rpt6-Rpt3 intermediate is not found in cells, while the other module, Rpt4-Rpt5, is readily available 65 . This suggests that the different modules assemble independently, and the formation of the Rpt6-Rpt3 module may be a rate-limiting step in RP assembly 65 . In cell lysates, Adc17 is found in a complex with Rpt6 and not in higher assemblies, suggesting that Adc17 is rapidly released after the Rpt6-Rpt3 pairing 65 . RP lid assembly. Recombinant RP lid subunits can assemble in the absence of the CP or RP base 22, 74 . Lid formation is initiated by the formation of two intermediates: one composed of Rpn5-6, Rpn8-9 and Rpn11 and the other composed of Rpn3, Rpn7 and Sem1 (reFs 74, 75 ).
Intermediates self-assemble through a helical bundle formed by the C-terminal helices of lid subunits 76 . After association of these two intermediates, the last lid subunit, Rpn12, is incorporated (Fig. 3 ). Rpn12 incorporation triggers conformational changes of the lid, which becomes competent for binding to the base 77 .
Association between the CP and the RP The association of the RP at one or both ends of the CP is crucial for the function of the 26S proteasome because the RP controls essential steps in proteasomal degradation: substrate recognition, deubiquitylation, The assembly of the regulatory particle (RP) base and the assembly of the RP lid occur independently of each other. The base is composed of ten subunits, six regulatory particle triple-A (Rpt) proteins and four regulatory particle non-ATPase (Rpn) proteins, and the lid is composed of nine Rpn proteins. The assembly of the base is assisted by five RP assembly chaperones (RACs), which ensure that the base subunits are properly assembled together. The lid is suggested to self-assemble through the formation of a helical bundle consisting of the C-terminal helices of lid subunits. After completion of the base and the lid, these two subassemblies associate to form a mature RP. Adc17 , ATPase dedicated chaperone of 17 kDa; Hsm3, DNA mismatch repair protein Hsm3. nATure revIeWS | MOleCulaR Cell BiOlOgy unfolding, translocation and opening of the CP gate ( Fig. 1 ). All these steps ensure a selective degradation of proteins. RP-CP association is mediated by the insertion of the C-terminal HbYX (Hb: hydrophobic; Y: tyrosine or phenylalanine; X: any amino acid) motifs of Rpt proteins into the α-pockets 67, 78 . This interaction induces conformational changes of the CP, displacing the N-terminal tails of the α-subunits from the centre of the CP channel to open the CP gate when the substrate is engaged 7 . Interestingly, Pba1 and Pba2 also contain HbYX motifs, explaining how the Pba1-Pba2 heterodimer prevents premature RP-CP association 52 . Similarly, Nas6, by interacting with Rpt3, sterically clashes with CP binding, which prevents premature docking of the RP to the CP 66, 79 . Additionally, Nas6 obstructs the RP base-lid association and thus has two functions in proteasome assembly 71 . Structural insights into the RP have also shown that the lid subunits Rpn5 and Rpn6 form finger-like structures that contact the CP subunits α1 and α2, respectively 22 . This unexpected interaction between the lid and the CP suggests that Rpn5 and Rpn6 enhance and stabilize the association between the RP and the CP 22 .
Substrate recognition by the proteasome An important aspect of the regulation of proteasomal degradation is achieved by controlling access of substrates inside the proteasome. Ubiquitylated proteins are directly recognized by the proteasome by three ubiquitin receptors, which are the intrinsic and stoichiometric proteasome subunits Rpn1, Rpn10 and Rpn13 (reFs 7, 14, 80 ). Rpn10 and Rpn13 are not essential in yeast 81 , suggesting that they have overlapping functions, unlike Rpn1, which is vital 80 . Liver-specific deletion of either Rpn10 or Rpn13 in adult mice is tolerated, whereas loss of both subunits causes severe liver damage with accumulation of polyubiquitylated conjugates 82 . However, Rpn10 deletion in mice embryos causes embryonic lethality, indicating that specific Rpn10 functions are important for mammalian development 83 . In yeast, shuttling factors UV excision repair protein Rad23, ubiquitin domain-containing protein Dsk2 and DNA damage-inducible protein 1 (Ddi1) escort ubiquitylated substrates to the proteasome 7, 14, 80 . The shuttling factors are UBL-UBA proteins; they bind to the proteasome through a ubiquitin-like (UBL) domain and to ubiquitin chains with a ubiquitin-associated (UBA) domain. These shuttling factors and the intrinsic substrate receptors coordinate substrate degradation, and their requirement varies for different proteins.
Substrate degradation is coupled to deubiquitylation 7 , which is an important element of control for proteasomal degradation exerted by proteasome-associated DUBs 84 . In a manner conceptually similar to the ubiquitin receptors, one DUB is an intrinsic proteasome subunit, and others are associated factors. Rpn11 is a proteasome DUB that cleaves the ubiquitin chains after the substrates have been irreversibly engaged into the narrow proteasome entry channel 84 . Ubiquitin C-terminal hydrolase 14 (USP14; Ubp6 in yeast) and ubiquitin C-terminal hydrolase UCH37 (also known as UCHL5) are DUBs that can associate with the proteasome and, by deubiquitylating substrates, modulate their fate 84 . Such enzymes are being examined as potential drug targets, as they play a pivotal role in regulating degradation 85 . Ubiquitin-independent degradation by the core 20S proteasome has also been reported 86, 87 , although much less is known about the mechanisms by which proteins can be targeted and degraded by the 20S in the absence of the 19S and ubiquitin. Regardless of the targeting mode, as the presence of an unstructured region is a prerequisite for the initiation of substrate degradation 14, 16 , protein unfolding could also be a direct mode of controlling degradation.
Regulation of proteasome subunit abundance
Because making the proteasome is energetically costly and because compromised proteasomal degradation leads to cell death 88 , cells have mechanisms to maintain adequate amounts of proteasomes.
Expression of the many different proteasome subunits must be tightly coordinated to produce the correct amount of each subunit. This is achieved through the controlled expression of proteasome subunits by a common transcription factor, Rpn4 in yeast 89, 90 . Rpn4 binds to a nonamer box (5′-GGTGGCAAA-3′) known as the proteasome-associated control element (PACE), which is present in the promoters of most proteasome subunits as well as some other stress genes 89 ( Fig. 4a) .
Remarkably, Rpn4 has a very short half-life (t 1/2 ~2 min) owing to rapid proteasomal degradation. As a result, Rpn4 abundance increases when proteasomal function is compromised, leading to increased expression of proteasome subunits 90 ( Fig. 4) . Consequently, deletion of rpn4 compromises cell fitness 90 . Rpn4 abundance is regulated not only by its rapid proteasomal degradation but also transcriptionally by various stress-inducible transcription factors, such as Yap1, Pdr1, Pdr3 and Hsf1, indicating that increasing expression of proteasome subunits might be a common mechanism to adapt to diverse challenging conditions 91 . Mammals also induce a concerted increase in expression of proteasome subunits in response to proteasome inhibition 92 . Two mammalian transcription factors have been proposed to fulfil the function of the yeast Rpn4: the nuclear factor erythroid 2-related factor 1 (NRF1 (also known as NFE2L1; Skn1 in yeast) and NRF2
(reFs 93, 94 ). Like Rpn4, NRF2 is an unstable protein that is stabilized upon redox stress to increase proteasome gene expression 93, 95 . NRF2 was initially proposed to increase expression of proteasome subunits when the proteasome is inhibited 96 . However, a later study attributed the induction of proteasome subunits following proteasome inhibition to NRF1 (reF.
94
).
NRF1 is an integral endoplasmic reticulum (ER) membrane protein that, under normal conditions, is constantly retrotranslocated from the ER to the cytosol, where it is rapidly ubiquitylated and degraded by the proteasome (Fig. 4b) . When proteasomal function is compromised, NRF1 escapes from proteasomal degradation and is cleaved by the aspartyl protease protein DDI1 homologue 2 (DDI2) to produce the active form of NRF1 (reFs 97, 98 ). Active NRF1 then translocates from the cytosol into the nucleus to induce expression of www.nature.com/nrm proteasome subunits 94, 97 ( Fig. 4b) . Both NRF1 and NRF2 are members of the Cap'n'Collar transcription factor family harbouring a basic-leucine zipper (bZIP) domain, which binds antioxidant response elements (AREs) found in the promoter of antioxidant response genes 99 . Interestingly, the promoters of several proteasomal subunit genes contain AREs, raising the possibility that NRF proteins increase proteasome levels under stress conditions 93,100-102 by binding to these AREs and that NRF1 and NRF2 are activated by different stresses.
In plants, two Arabidopsis thaliana NAM/ATAF1/ CUC2 (NAC) transcription factors, NAC53 (also known as ANAC053) and NAC78 (also known as ANAC078), have been identified as key regulators of genes encoding proteasome subunits. NAC53 and NAC78 induce the expression of proteasome components under proteotoxic stress, which is essential for the plant to survive proteasome inhibition [103] [104] [105] . As these transcription factors have probably evolved to ensure that proteasome homeostasis is adapted to the plant needs, it will be interesting to uncover the physiological pathways that are particularly sensitive to perturbations of this proteasome stress response.
Regulation of proteasome subunits assembly
Following the coordinated induction of proteasome subunits by designated transcription factors, the subunits need to be faithfully assembled to generate functional proteasomes. Proteasome assembly was initially thought to be a housekeeping process, but recent studies have revealed that this process is complex and tightly regulated.
Regulation of RP assembly. The first indication that assembly of RP subunits might be regulated came with the identification of the yeast RAC Adc17 (reF. 65 ). In a genetic screen for pathways that can compensate for proteasome dysfunction, Adc17 was identified as a potent suppressor of the proteasome defects caused by a thermosensitive mutation in Rpt6 (reF.
65
′ GGTGGCAAA ′ Fig. 4 | Transcriptional regulation of proteasome subunits. a | Transcriptional regulation of proteasome subunits in yeast. Regulatory particle non-ATPase 4 (Rpn4) is a transcription factor with an extremely short half-life (t 1/2 ~2 min). It is constantly degraded by the proteasome through both ubiquitin-dependent and ubiquitin-independent pathways under normal growth conditions. Ubiquitin-dependent degradation of Rpn4 is mediated by a complex formed by the ubiquitinconjugating enzyme E2 2 (Rad6) and the E3 ubiquitin-protein ligase Ubr2. Upon proteasome inhibition or overload, Rpn4 is stabilized and translocates to the nucleus, where it binds to a nonamer box (5′-GGTGGCAAA-3′) referred to as the proteasome-associated control element (PACE), which is present in the promoters of most proteasomal subunit genes. This increases expression of proteasome subunits. b | Transcriptional regulation of proteasome subunits in mammals. Nuclear factor erythroid 2-related factor 1 (NRF1) controls proteasome subunit expression in mammals. NRF1 is constantly retrotranslocated to the cytosol, where it is rapidly ubiquitylated and degraded by the ubiquitin-proteasome system (UPS) with a half-life of only ~12 minutes. When the proteasome is inhibited or overloaded, the stabilization of NRF1 after retrotranslocation allows NRF1 to be cleaved by the aspartyl protease protein DDI1 homologue 2 (DDI2). The resulting active form of NRF1 translocates to the nucleus where it binds antioxidant response elements (AREs) and activates the transcription of its target genes, including those encoding the proteasome subunits. This response is referred to as the proteasome bounce-back response. ER , endoplasmic reticulum; Ub, ubiquitin.
Adc17 is induced by stress conditions such as heat shock and ER stress, independently of Rpn4 (reF.
). The pathway controlling stress-induced expression of Adc17 was recently found to involve signalling through the central stress and growth controller TOR (Box 2; Fig. 5 ). Inhibition of TOR complex 1 (TORC1), either pharmacologically or genetically, is sufficient to increase Adc17 levels, and this induction was shown to be dependent on the MAP kinase Mpk1 (reF.
106
). Remarkably, Mpk1 activation following TORC1 inhibition also induces all other known yeast RACs (Nas2, Nas6, Hsm3 and Rpn14). This coordinated increase in RACs is essential to augment proteasome assembly and for cell survival under challenging conditions that require increased proteolytic capacity 106 (Fig. 5) .
Several lines of evidence indicate that Mpk1 acts post-transcriptionally by coordinating the expression of RACs and proteasome subunits at the translational level to increase proteasome abundance and enhance proteolysis 106 . Highlighting its importance, this adaptive proteasome assembly pathway is evolutionarily conserved, as mTOR and ERK5 (also known as MAPK7; the homologue of Mpk1) regulate RACs and 26S proteasome assembly in mammalian cells 106 .
In agreement with the increased translation of proteasome components following TORC1 inhibition 106 , quantitative profiling of initiating ribosomes revealed that translation of proteasome components and proteasome activity is robustly enhanced upon starvation 107 . Thus, there is converging evidence indicating that the cellular levels of the functional proteasome are regulated and that this regulation is important for cell survival and physiology.
Regulation of CP assembly. Ectopic overexpression of Rpn4, which promotes the transcription of proteasome subunit-encoding genes, further increases the levels of functional proteasomes in wild-type cells that already contain high basal levels of proteasomes 108 . Surprisingly, Rpn4 overexpression has been suggested to also increase the transcription of genes encoding proteasome assembly chaperones to various degrees, although no PACE element could be found in their promoter regions, with the exception of Nas6 (reF. 108 ). This increase is particularly pronounced for the CP chaperones, which contain a minimum sequence, referred to as PACE-core, that could function as an Rpn4-responsive element 108 . It will be interesting to elucidate whether this Rpn4-mediated increase is direct or indirect, as this could reveal new nodes of regulation.
Recently, several studies highlighted that CP assembly is also regulated 106, 109 ; however, the underlying molecular mechanisms remain to be fully characterized. An indication of CP assembly regulation came from the observation that the abundance of the yeast proteasome assembly chaperones Pba1 and Pba2 is increased by tunicamycin, which causes accumulation of misfolded proteins in the ER, while the levels of Pba3-Pba4 dimers remain unchanged. This increase in Pba1 and Pba2 was associated with enhanced CP assembly 106 . It will be interesting to identify the pathway controlling the stress inducibility of Pba1 and Pba2 expression. Pba3 and Pba4 levels were reported to increase following mitochondrial protein import perturbation as a consequence of the accumulation of mitochondrial precursors in the cytosol 110 . Moreover, the stability and dimerization of the CP assembly chaperones PAC1 and PAC2 (the human homologues of Pba1 and Pba2, respectively), as well as proteasome activity, were found to increase upon ER stress, and this increase was proposed to be mediated by inactive rhomboid protein 1 (iRhom1) 111 . iRhom1 is a member of the rhomboid-like family of proteases that lacks protease activity 112 . iRhom1 is located in the ER and has been involved in membrane protein trafficking and in ER-associated protein degradation (ERAD) [112] [113] [114] . How iRhom1 regulates the stability of PAC1-PAC2 dimers and promotes proteasome activity remains unknown.
The transmembrane domain recognition complex (TRC) pathway, which controls membrane insertion of tail-anchored proteins, has also been proposed to regulate CP assembly (Fig. 5) , as loss of either TRC40 or large proline-rich protein BAG6 chaperones, two mammalian 
Rhomboid-like family of proteases
A family of pseudoproteases (proteolytically inactive) that bind membrane proteins to regulate their fate.
Box 2 | TORC1 complex in yeast and mammals
The Saccharomyces cerevisiae Tor complex 1 (TorC1) is composed of three essential components, Tor1 or Tor2, kontroller of growth protein 1 (Kog1) and lethal with Sec13 protein 8 (lst8), and one non-essential protein, Tco89 (reFs 159, 206, 207 ). The Tor1 and Tor2 subunits harbour the kinase catalytic activity, whereas the other components regulate the assembly and stability of TorC1 as well as its subcellular localization and substrate recruitment 158, 159 . The mammalian complex, mTorC1, comprises three orthologues of the essential subunits of the yeast TorC1 complex, mTor (Tor1 and Tor2 in yeast), regulatory protein associated with mTor (raptor; Kog1 in yeast) and mammalian lst8 (mlST8; lst8 in yeast) [208] [209] [210] , and two additional inhibitory subunits, proline-rich AKT substrate of 40 kDa (PrAS40) and DeP domain-containing mTor interacting protein (Deptor) [211] [212] [213] (see the figure). TorC1 is a stress-responsive and nutrient-responsive complex that adapts cell metabolism to the cell requirements, and one essential trigger of its activation is amino acid availability. TorC1 does not sense amino acid availability directly but instead through sensors. For example, sensors for arginine and leucine have been recently identified and referred to as cellular arginine sensor for mTorC1 (CASTor1) and sestrin 2, respectively [214] [215] [216] [217] . It is possible that more sensors will be discovered. under nutrient-rich conditions, mTorC1 activation favours growth in part by promoting the synthesis of new cellular components, including proteins. Well-characterized mTorC1 targets controlling translation in mammals are the ribosomal protein S6 kinase β1 (S6K1) and the eukaryotic translation initiation factor 4e (eIF4e) binding proteins (4e-bPs) 158, 159 . mTorC1 also promotes anabolism by repressing the two degradative machineries, the autophagy-lysosome system and the ubiquitin-proteasome system (uPS). under various stress conditions, such as nutrient scarcity, mTorC1 is inhibited, which decreases global protein synthesis while derepressing degradative machineries 106, 158, 159, 167 . This well-orchestrated response is essential to maintain an adequate and functional proteome in cells.
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TRC components, leads to CP assembly defects 115 . Although the precise mechanisms by which the TRC pathway regulates CP assembly remain to be established, it has been proposed that TRC40 and BAG6 may facilitate the incorporation of β-subunits on the α-ring or stabilize CP assembly intermediates 115 . miR-101, which is a potent tumour suppressor, was also shown to regulate proteasome assembly 109 , highlighting a possible link between proteasome assembly and cancer. miR-101 targets the mRNA encoding the CP assembly chaperone POMP to rapidly decrease POMP protein levels and thus inhibit proteasome assembly 109 (Fig. 5) .
In recent years, it has become apparent that the accumulation of misfolded proteins leads to an increase in proteasome assembly. Regulated proteasome assembly and the resulting capacity to increase proteasomal degradation are important to enable the clearance of misfolded proteins that could be deleterious to cells. Although it had been known for a long time that ubiquitylation of proteasome substrates dictates their degradation rates, the finding that proteasome abundance and assembly can be finely tuned to the cellular requirements indicates that the mechanisms that regulate proteasomal degradation to meet cellular needs and maintain cell viability are more complex than previously appreciated.
Regulation of RP-CP association. RP-CP association is crucial for proteasome activation because the N-terminal tails of α-subunits form a gate to prevent access in the centre of the α-ring 32, 116, 117 . RP-CP association is reversible, as the 26S proteasome can disassemble into stable RP and CP [118] [119] [120] (Fig. 5) .
As purified RP and CP can associate in vitro without additional factors, it is believed that RP-CP association occurs spontaneously 121, 122 . It could be different in cells, The transcription of proteasome-related genes is coordinated by the transcription factors regulatory particle non-ATPase 4 (Rpn4) in yeast and nuclear factor erythroid 2-related factor 1 (NRF1) and NRF2 in mammals. Under challenging conditions, inhibition of the stress and growth controller TOR complex 1 (TORC1) signals to MAP kinase Mpk1 to increase assembly of the regulatory particle (RP). Core particle (CP) assembly is also a regulated process, with the transmembrane domain recognition complex (TRC) pathway and inactive rhomboid protein 1 (iRhom1) promoting CP assembly while miR-101, targeting proteasome maturation protein (POMP) mRNA , interferes with CP assembly. The association of the RP at one or both ends of the CP will form the singly and doubly capped proteasome, respectively. RP-CP association is mediated by the insertion of the carboxy-terminal HbYX (Hb: hydrophobic; Y: tyrosine or phenylalanine; X: any amino acid) motifs of regulatory particle triple-A protein (Rpt) proteins into the pockets formed by two adjacent α-subunits. Various proteins have been proposed to play a role in the regulation of RP-CP association both in yeast (Ecm29 and heat shock protein 90 (Hsp90)) and in mammals (HSP90 and RPN6). Hsm3, DNA mismatch repair protein.
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given that several factors regulating RP-CP association have been identified. One such factor is the chaperone and heat shock protein 90 (Hsp90), which has been implicated in various ways in maintaining the integrity of the 26S proteasome [123] [124] [125] [126] (Fig. 5) . The RP base subunit Rpn6 may also regulate RP-CP association because it binds directly to the α2 subunit of the CP 22 (Fig. 5) .
Ectopic expression of RPN-6.1 in Caenorhabditis elegans was found to increase proteasome activity and to improve resistance to proteotoxic stresses 127 . RPN6 is also important to maintaining high levels of proteasome in human embryonic stem cells 128 . The HEAT-like repeat protein Ecm29 associates with the proteasome in yeast and recognizes aberrant RP-CP assemblies that accumulate in strains compromised for proteasome assembly or maturation, such as in ump1Δ cells 58, 129 or in α-pocket lysine mutants, in which immature β-subunits are incorporated 130 . When bound to faulty proteasomes, Ecm29 represses proteasomal degradation by inhibiting both proteasomal ATPase activity and CP gate opening [129] [130] [131] [132] . Moreover, Ecm29 promotes RP-CP dissociation under oxidative stress by interfering with the binding between the RP and the CP 120, 133 . Some interesting questions to address in future studies include how Ecm29 is specifically recruited to the 26S proteasome under oxidative stress and whether Ecm29-bound aberrant proteasomes are disassembled or degraded.
The tightly regulated degradation of the majority of cellular proteins is executed by the 26S proteasome. It has also been proposed that the CP could degrade proteins that are inherently unstable or unstructured and that degradation of such proteins occurs by default 134 . It was shown that degradation by the CP proteasome does not require ubiquitin tagging but is dependent on the presence of unstructured regions in proteins; however, to date, little is known about CP-mediated protein degradation 87 .
Regulation of RP-CP association by post-translational modifications. Post-translational modifications of the proteasome offer additional possibilities to regulate proteasomal degradation, as reviewed elsewhere 135, 136 . Protein phosphorylation is one of the most abundant post-translational modifications, and diverse kinases and phosphatases regulate the proteasome 137 . Attesting to the importance of this modification for proteasome assembly, treatment of purified proteasome with alkaline phosphatase leads to its dissociation into the CP and RP 138 . One of the first kinases reported to phosphorylate proteasome subunits is the cAMP-dependent protein kinase A (PKA) 139 . Serine 120 (S120) of Rpt6 was first shown to be phosphorylated by PKA and dephosphorylated by protein phosphatase 1-γ (PP1γ). Rpt6 phosphorylation by PKA regulates the 26S proteasome 138, 140, 141 , possibly by facilitating the interaction between Rpt6 and the CP subunit α2 (reF.
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PKA activation has been shown to increase proteasome activity and, as a consequence, to have a protective effect in several models of neurodegenerative disease 140, 142, 143 . However, these findings have been contradicted by the observation that Rpt6 phosphorylation did not occur following rolipram-mediated PKA activation, whereas the RP subunit Rpn6 was selectively phosphorylated at serine 14 (reF.
144
). Overexpression of the phosphomimetic Rpn6-S14D mutant stimulated the degradation of short-lived proteasome substrates and aggregation-prone proteins, while the phospho-dead Rpn6-S14A mutant had the opposite effect 144 . Rpn6 phosphorylation was associated with increased levels of the 26S proteasome, especially the RP 2 -CP 144 , which is consistent with the proposed function of Rpn6 as a mediator of RP-CP association 22 . In light of these discrepancies, it will be important to clarify the contribution of each PKA target in PKA-mediated increase of the RP-CP proteasome.
Another illustration of phosphorylation and dephosphorylation regulating the proteasome is the ubiquitin-like domain-containing CTD phosphatase 1 (UBLCP1) 145 . UBLCP1 was shown to bind Rpn1 via its UBL domain and to subsequently dephosphorylate the AAA + -ATPase Rpt1 subunit. UBLCP1 is a proteasome phosphatase regulating nuclear proteasome assembly, especially the association between the RP and the CP 145, 146 . A screen using a salicylic fragment-based library identified a potent UBLCP1 inhibitor (compound 13; half-maximal inhibitory concentration (IC 50 ) of 1 µM) that increases nuclear proteasome activity in cells. The therapeutic potential of this compound to correct conditions caused by protein misfolding remains to be determined.
ADP ribosylation is another post-translational modification that regulates a proteasome-binding protein, PI31. ADP ribose-bound PI31 has been proposed to selectively interact with two RACs, dp27 and dS5b (the fly homologue of the yeast Nas2 and Hsm3, respectively), to promote 26S proteasome assembly 147 . However, another work failed to recapitulate these findings in vivo 148 , thereby questioning the physiological relevance of PI31 in the regulation of the 26S proteasome.
Large-scale analyses of post-translational modifications of the proteasome have revealed more than 345 post-translational modifications on the 26S proteasome, which can be divided into 11 different types: phosphorylation, ubiquitylation, succinylation, N-acetylation, N-myristoylation, N-methylation, oxidation, O-glycosylation, sumoylation, poly(ADP-ribosyl) ation and truncation 149 . The functional consequences of these modifications remain, for the majority, completely unknown, and their characterization will be an important subject of future studies 149 .
Proteasomal degradation and autophagy
It has long been known that impairment of proteasomal degradation induces autophagy. This has been seen in numerous experimental systems, from cells to organisms and from yeast to mammals 150 . The molecular connections between these two degradation systems occur at multiple levels. One example is the accumulation of proteasome substrates, where impairment of proteasomal degradation may be compensated by autophagic degradation.
In addition to bulk autophagy, which is induced upon nutrient starvation and is regarded as non-selective, autophagy can also be selective. Importantly, ubiquitin www.nature.com/nrm serves as a signal to target proteins for degradation by both systems 151 . Selective autophagy employs autophagy receptors to target cargo to autophagosomes. These include p62, next to BRCA1 gene 1 protein (NBR1), nuclear domain 10 protein 52 (NDP52; also known as CALCOCO2), valosin-containing protein (VCP) and optineurin, which are modular proteins that bind on one side to ubiquitin on cargo and, on the other side, to autophagosome-bound proteins, members of the LC3 family, through an LC3-interacting region 151 . Because unfolding of proteins is required for proteasomal degradation, it is believed that the proteasome degrades soluble proteins, whereas organelles or protein aggregates are degraded by autophagy. One well-established illustration of concerted actions between these two degradative machineries is the clearance of multiple aggregation-prone proteins such as huntingtin or α-synuclein 152 . The proteasome is responsible for the degradation of most misfolded proteins to prevent them from forming large aggregates. When the proteasome is defective or overwhelmed, misfolded proteins accumulate and form large oligomers and aggregates, which are targeted by autophagy 151 . Thus, both degradative machineries collaborate to clear misfolded proteins and maintain the functionality of the proteome. It remains unclear whether autophagy inhibition can induce compensatory proteasome activation. With the popular notion that the proteasome degrades soluble substrates and autophagy degrades larger cellular structures, it is difficult to imagine that proteasomal degradation could functionally replace autophagy. A form of autophagy-proteasome crosstalk occurs when the 26S proteasome is degraded by autophagy, a process that was discovered in plants and referred to as proteaphagy 153 . Proteaphagy occurs in plants upon nitrogen starvation and proteasome inhibition and is mediated by Rpn10, which binds to both ubiquitylated proteasome and ATG8, acting as a proteaphagy receptor 153 . Similar results have been observed in yeast, whereby ubiquitin-binding protein Cue5 is the proteaphagy receptor 154, 155 . Proteaphagy has also been described in human cells, with p62 being important for autophagic targeting of the 26S proteasome 156 . Thus, autophagy may control proteasome levels and, in this way may affect, albeit indirectly, proteasomal degradation.
The mechanisms described highlight the crosstalk between the proteasome and autophagy at the level of substrate degradation. However, because degradation of substrates recycles amino acids, an important component of the crosstalk between these two degradative pathways is orchestrated by amino acid homeostasis. As we discuss below, TORC1 integrates amino acid metabolism and levels of protein degradation via both the proteasome and autophagy.
TORC1 controls proteasome biogenesis A high supply of nutrients favours growth and anabolic processes, whereas a scarcity of nutrients promotes catabolic processes to spare and recycle existing resources for cell survival. TORC1 is a central controller of cell growth and cellular homeostasis in all eukaryotes 157, 158 . TORC1 senses amino acid availability to balance protein synthesis and degradation (Fig. 6) . In nutrient-rich conditions, TORC1 activation favours growth in part by promoting the synthesis of new proteins (Box 2; Fig. 6 ). This increase in anabolic processes is associated with repression of cellular catabolism through the phosphorylation and inhibition of the serine/threonine-protein kinase ULK1 and the transcription factor EB (TFEB), which are involved in autophagosome formation and transcription of autophagy-lysosome genes, respectively [159] [160] [161] [162] . Conversely, in nutrient-limiting conditions, TORC1 inhibition represses anabolic processes and cell growth while stimulating catabolism in order to mobilize stored energy and resources to maintain essential cellular processes and ensure cell survival (Fig. 6) .
It is well established that TORC1 inhibition induces autophagy 151, 163 . In addition, it has recently been shown that the inhibition of TORC1 increases proteasome assembly and abundance 106 . These findings indicate that TORC1 coordinates proteasome assembly and abundance with growth and cellular metabolism (Fig. 6) . It is noteworthy that this increase in proteasome assembly and abundance following TORC1 inhibition is transient 106 . A similar transient increase in proteasome Under nonlimiting nutrient conditions, TOR complex 1 (TORC1) is activated to promote anabolic processes, such as the synthesis of nucleotides, lipids and proteins. This elevated production of the building blocks of cellular components is associated with the repression of catabolic processes to favour cell growth. Diverse stresses, including nutrient scarcity , inhibit TORC1 to decrease cellular anabolism and increase catabolic processes, including the autophagy system and the ubiquitin-proteasome system (UPS). Elevated protein catabolism enables the degradation of unwanted proteins into free amino acids, which will support the synthesis of new stress proteins. This metabolic reprogramming of the cells is essential to maintain cell viability. Kog1, kontroller of growth protein 1; Lst8, lethal with Sec13 protein 8.
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). Interestingly, the return to basal levels of the proteasome following TORC1 inhibition is accompanied by an increase in autophagy, suggesting that autophagic degradation of the proteasome or proteaphagy is one of the causes of the transient nature of the increase in the proteasome. In agreement with this model, the proteasome was recently found to be a substrate of the autophagy-lysosome system [153] [154] [155] [156] . Another study has reported that uncontrolled activation of TORC1 in mammalian cells depleted of TSC2 (encoding tuberous sclerosis complex 2; also known as tuberin, a negative regulator of TORC1) and subjected to serum starvation increases the level of active proteasomes in an NRF1-dependent manner 165 . One possible explanation for these contradictory observations lies within the specific experimental conditions used 165 , as prolonged hyperactivation of TORC1 in cells cultured in the absence of serum could have elicited adaptive mechanisms leading to increased levels of proteasome.
In line with TORC1 repressing diverse catabolic processes, mTORC1 inhibition increases protein ubiquitylation and degradation in human cells. mTORC1-dependent ubiquitylation is rather selective, as it preferentially targets growth-related factors, such as the 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase 166, 167 . Amino acid homeostasis plays a central role integrating proteasome assembly and abundance with growth and cellular metabolism. The proteasome is important both as a protein destruction machine and as a recycler of amino acids, and proteasome inhibition results in a shortage of amino acids 12, 168 (Fig. 6 ). The importance of supplying amino acids is highlighted by the observation that proteasome inhibition is lethal for cells and organisms 83, 169, 170 , but yeast and mammalian cells as well as flies survive proteasome inhibition when supplemented with amino acids 12 .
The amino acid scarcity resulting from proteasome inhibition causes a starvation-associated stress that functions as a signal to induce both the integrated stress response and autophagy 12 in an attempt to rescue amino acid homeostasis. The integrated stress response consists of decreasing the rates of protein synthesis, thereby decreasing the consumption of amino acids when the supply is limited. In parallel, cells induce autophagy to recycle intracellular components and thereby provide nutrients to compensate for the shortage resulting from proteasome inhibition (Fig. 6) . Thus, amino acid scarcity is a signal that activates autophagy when the proteasome is inhibited, and this occurs through TORC1 (reF. 12 ).
Similar to proteasome inhibition, inhibition of the regulator of proteasomal degradation p97 also disturbs amino acid homeostasis and, consequently, protein synthesis 171 . This further supports the notion that one of the vital functions of the proteasome is to recycle amino acids.
Proteasome deregulation in ageing and disease
The proteasome degrades a very large number of cellular proteins and, in this way, controls many cellular processes. With such a central role, it is not surprising that dysfunction of the proteasome is associated with diverse diseases.
Neurodegeneration. Dysfunction of the proteasome has been associated with a broad range of diseases. Failure to degrade abnormal, misfolded, mutant or damaged proteins leads to their accumulation, which can be deleterious for cells. The accumulation of proteins of abnormal conformation in the form of insoluble aggregates is a hallmark of neurodegenerative diseases 153, 172 , suggesting that the cellular capacity to neutralize aggregation-prone proteins declines with age. Indeed, although ageing is probably a multicomponent problem, a decline in proteasomal degradation has been associated with ageing (see references [173] [174] [175] for excellent reviews on this topic). As protein degradation has a crucial role in preventing the accumulation of aggregation-prone proteins, considerable effort has been invested in trying to increase the cellular capacity for protein degradation with the view that this could slow down ageing or neurodegenerative diseases. For example, increasing the cellular autophagic capacity, by inhibition of mTOR1 for example, has received a lot of attention 151 . This is because protein aggregates associated with neurodegenerative diseases are thought to be too large for degradation by the proteasome. However, as discussed above, inhibition of TORC1 increases autophagy and proteasomal degradation 106, 167 . Thus, it will be interesting to re-evaluate the contribution of proteasomal degradation to the reported benefits of TORC1 inhibitors. It is also important to keep in mind that while protein aggregates may be too large to be degraded by the proteasome, the precursors of these aggregates, mutant huntingtin, α-synuclein and superoxide dismutase (SOD1), are proteasome substrates 176 . Thus, increasing proteasomal degradation in a controlled manner to decrease accumulation of misfolded proteins before they form large inclusions is an attractive possibility. Inhibitors of the proteasome-associated DUB USP14 have been proposed for such a purpose 85 , although this has been the subject of controversy 177 . Uncovering new nodes of regulation of proteasomal degradation provides new opportunities to manipulate this system for potential therapeutics.
Targeting the proteasome in cancer. Age is also one of the greatest risk factors for cancer 178, 179 owing to the age-dependent accumulation of genomic mutations 180 . Such mutations may cause a change in the levels of protein expression and/or a stochiometric imbalance in expression of subunits of protein complexes. This in turn may cause the accumulation of misfolded or over produced proteins, potentially explaining why cancer cells are often 'addicted' to high levels of proteasomes. This Achilles heel has been exploited, and proteasome inhibitors are used to treat some cancers 180, 181 . Recent advances in the use of proteasome inhibitors in cancer therapy have been comprehensively reviewed elsewhere 180, 181 . Bortezomib was the first proteasome inhibitor to be brought to the clinic and is used for the treatment of multiple myeloma 180, 181 . Although proteasome inhibitor drugs have shown benefits, relapses are frequent because resistance to the treatment almost inevitably arises. Thus, understanding the mechanisms underlying resistance to proteasome inhibitors is an area of intense research. Interestingly, knockdown of RP subunits increases Integrated stress response stress response signalling pathway that is controlled by four kinases, gCN2, PKr, PerK and Hri, that phosphorylate eiF2α in response to diverse cellular stresses.
p97
An AAA + -ATPase involved in a variety of cellular processes through its ability to pull proteins out of membranes or protein complexes for proteasome degradation.
www.nature.com/nrm resistance to proteasome inhibitors 182 . In light of the recent findings that cells adjust proteasome abundance to their needs, it is reasonable to speculate that cells adapt to the reduction of RP subunits by inducing a response that leads to resistance to proteasome inhibition. It will be interesting to identify such mechanisms.
Several lines of evidence highlight the notion that the perturbation of proteasome assembly can have an effect on tumorigenesis. The first indication came with the observations that two out of the four RACs, p27 (also known as PSMD9; Nas2 in yeast) and p28 (also known as PSMD10; Nas6 in yeast), promote cancer progression [183] [184] [185] [186] . For example, the loss of p27 in breast cancer cells decreases cell resistance to radiotherapy 183, 184 , which is in agreement with RACs being regulated by different stresses 97 . There are also robust links between the RAC p28 and cancer, with p28 being considered an oncoprotein 185, 186 . The role of p28 in cancer was highlighted long before its function as a proteasome assembly chaperone was identified, and the interpretation of some early studies may need to be revisited accordingly. More recently, it has been reported that cellular tumour antigen p53 missense mutants cooperate with NRF2 in activating the transcription of proteasome genes as well as those encoding the RACs, leading to higher levels of proteasome activity 187 . These findings highlight the importance of the regulation of proteasome assembly in cancer.
miR-101, which targets the CP chaperone POMP mRNA to rapidly decrease POMP protein, is a potent tumour suppressor that is downregulated in a variety of cancers 188 . The tumour suppressor function of miR-101 is completely abrogated by the expression of miR-101-resistant POMP, showing that POMP targeting is necessary for miR-101-mediated tumour suppression 109 . Remarkably, POMP inhibition overcomes tumour cell resistance to the proteasome inhibitor bortezomib 109 .
Moreover, it has been independently shown that POMP overexpression in drug-naive cells confers resistance to bortezomib and is associated with increased levels of NRF2, which gives rise to a positive feedback loop by binding to the POMP promoter 189 . Another possible level of intervention has been identified with the selective peptide inhibitor of PAC3 dimerization 190 , which has long-term cytotoxicity in human cervical carcinoma cells 191 . Thus, inhibiting proteasome assembly could be a promising anticancer strategy. Interfering with proteasome assembly could be a valuable therapeutic strategy to impede proteasome functions either alone or in conjunction with existing drugs inhibiting the catalytic activity of the proteasome, such as bortezomib.
Conclusions and perspectives
The identification of proteasome assembly chaperones has revealed that proteasome assembly is a highly complex and tightly regulated process that is integrated with cellular metabolism via the stress and growth controller TORC1. The regulation of proteasome homeo stasis is an emerging field of research, and it is likely that more nodes of regulation of proteasome assembly and activity remain to be elucidated. It is interesting to note that ribosome biogenesis requires more than 200 factors. By analogy, one might wonder how many more proteasome assembly factors remain to be discovered. As the proteasome has a crucial role in regulating cell function that is relevant to diseases, understanding and modulating assembly mechanisms could open up valuable therapeutic intervention opportunities relevant to diverse human age-related diseases, including cancer and neurodegeneration.
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